Clinical Trial Update: First-in-Human Study of MS201408-0005A as Single Agent and in Combinations [Phase 1]

View source ↗

Summary

First-in-human Phase 1 trial of MS201408-0005A as a single agent and in combinations in metastatic or locally advanced unresectable solid tumors; study terminat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Or Locally Advanced Unresectable Solid Tumors

Drugs mentioned

• MS201408-0005A

Snippet

Sponsor: EMD Serono Research & Development Institute, Inc. | Conditions: Metastatic or Locally Advanced Unresectable Solid Tumors | Phase 1 | Status: TERMINATED | Results posted: 2020-02-06